twoXAR

twoXAR Pharmaceuticals is a drug discovery company focused on first-in-class small molecules. The company currently has a development portfolio of over 18 diseases. twoXAR can save years in drug development while achieving a 30-fold higher hit rate at the in vivo efficacy milestone compared to traditional methods.